IFRD2 (interferon related developmental regulator 2) functions as a ribosome-binding protein that acts as an inhibitor of mRNA translation by promoting ribosome inactivation 1. The protein associates with the P- and E-sites of the ribosome and inserts a C-terminal helix into the mRNA exit channel to preclude translation 1. Structural studies reveal that IFRD2 binds ribosomes containing a tRNA occupying a noncanonical 'Z site', providing a mechanism for translational repression during cellular processes requiring reduced protein synthesis 1. Beyond its role in translation control, IFRD2 expression appears to be modulated in disease contexts. In chr3 hepatitis B patients, low IFRD2 expression is associated with poor interferon therapy efficacy 2. The gene has also been implicated in inflammatory bowel disease pathways, where appendicitis-appendectomy modulates IFRD2 expression as part of protective mechanisms against experimental colitis 3. Additionally, IFRD2 has been identified as a potential candidate gene in biliary atresia susceptibility through exome sequencing studies 4. The protein's dual role in translation regulation and immune-inflammatory responses suggests it may serve as a molecular link between cellular stress responses and disease pathogenesis.